Trastuzumab deruxtecan (Enhertu) is indicated for the treatment of adult patients with unresectable or metastatic HER2-positive breast cancer
Five batches across four programs of Biocon Academy participated in the graduation ceremony
The products are slated to be manufactured at the Ankleshwar facility and is expected to start contributing meaningfully to the revenue from FY25
Fischer Chemic will make an entry into the growing market of diagnostic imaging industry with innovative and disruptive technologies
Dr. Reddy's has been awarded 'Gold Medal' status by EcoVadis
Biocon Biologics is one among the three pharmaceutical companies from India to be featured on this year's list
Receives registration of Valganciclovir powder for oral solution in Germany
Expands patient reach to remotest towns by furthering investment in GoApptiv
The Regional Reference Laboratory in Chennai is equipped with cutting-edge diagnostic technologies
Subscribe To Our Newsletter & Stay Updated
